Exothera SA
Ouverture de faillite 139.2 FTEThe score of Exothera shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Change 2020 → 2023: Revenue +1468 % Equity +72 % Total assets +211 % Headcount (avg FTE) +209 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Exothera's annual accounts
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Revenue | €9.95m | |||
| Net result | −€31.4m | |||
| Equity | €4.64m | |||
| Cash | €2.31m | |||
| EBITDA | −€25.6m | |||
| Total assets | €35.7m |
Filed annual accounts
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 22 Jul 2022
- Year ended 31 Dec 2020filed on 18 Jun 2021
Exothera's financial analysis
- Solvency13.0%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Exothera
Exothera's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0744.643.660
- VAT number
- BE0744643660
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 02 Mar 2020
- Registered office
- 6040 Charleroi
- Size
- Medium · 139.2 FTE
- Latest accounts
- 2023 · filed on 04 Jul 2024
- Activity
- Manufacture of medicaments (NACE 21201)
Exothera (SA) has been based in Charleroi since 2020, active in: manufacture of medicaments. For 2023, it reports revenue of €9.95m, a net loss of €31.4m and equity of €4.64m. With 139.2 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 13.0%, below the median of its sector (34.4%).
Companies similar to Exothera
Companies in the same business, of comparable size and area, outside its group.
- Cellistic Manufacture of pharmaceutical preparations Mont-Saint-Guibert · balance sheet €41.6m
- Kaneka Eurogentec Manufacture of pharmaceutical preparations Seraing · balance sheet €115.4m
- S.M.B. Technology Manufacture of pharmaceutical preparations Marche-en-Famenne · balance sheet €56.8m
- KELA - Kempisch Laboratorium - Kela Laboratoria Manufacture of pharmaceutical preparations Hoogstraten · balance sheet €63.2m
- Galephar M/F Manufacture of pharmaceutical preparations Marche-en-Famenne · balance sheet €21.6m
- ELI Lilly European Clinical Trial Services Manufacture of medical and dental instruments and supplies Mont-Saint-Guibert · balance sheet €57.4m
- Alcon Laboratories Belgium Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €107.2m
- Opella Healthcare Belgium NV/SA Manufacture of pharmaceutical preparations Machelen (Brab.) · balance sheet €32.3m
Frequently asked questions about Exothera
What is the revenue of Exothera?
According to the 2023 annual accounts filed with the NBB, the revenue of Exothera amounts to 9,954,953 €.
What is the VAT number of Exothera?
In Belgium, the VAT number is the company number prefixed with BE: BE0744643660 for Exothera, if the company is VAT-registered. Its company number (CBE) is 0744.643.660.
Where is the registered office of Exothera?
According to the CBE register, the registered office of Exothera is in 6040 Charleroi.
What is the equity of Exothera?
At the close of the 2023 financial year, the equity of Exothera amounts to 4,642,084 €, a solvency of 13.0% of total assets.
How many people work at Exothera?
139.2 full-time equivalents on average according to the 2023 social balance sheet.
Who manages Exothera?
The register lists 13 active mandates at Exothera. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Exothera
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →